IL272314A - Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease - Google Patents

Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease

Info

Publication number
IL272314A
IL272314A IL272314A IL27231420A IL272314A IL 272314 A IL272314 A IL 272314A IL 272314 A IL272314 A IL 272314A IL 27231420 A IL27231420 A IL 27231420A IL 272314 A IL272314 A IL 272314A
Authority
IL
Israel
Prior art keywords
nitrous oxide
lung disease
pulmonary hypertension
hypertension associated
treat pulmonary
Prior art date
Application number
IL272314A
Other languages
English (en)
Hebrew (he)
Original Assignee
Bellerophon Pulse Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellerophon Pulse Tech Llc filed Critical Bellerophon Pulse Tech Llc
Publication of IL272314A publication Critical patent/IL272314A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
    • A61M16/022—Control means therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1025—Respiratory system
    • A61M2210/1039—Lungs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/12—Blood circulatory system
    • A61M2210/125—Heart
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/30—Blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/40—Respiratory characteristics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL272314A 2017-08-30 2020-01-28 Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease IL272314A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762552022P 2017-08-30 2017-08-30
US201762611325P 2017-12-28 2017-12-28
PCT/US2018/048526 WO2019046415A1 (en) 2017-08-30 2018-08-29 USE OF INHALED NITRIC OXIDE FOR THE TREATMENT OF PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY DISEASE

Publications (1)

Publication Number Publication Date
IL272314A true IL272314A (en) 2020-03-31

Family

ID=65526008

Family Applications (2)

Application Number Title Priority Date Filing Date
IL272314A IL272314A (en) 2017-08-30 2020-01-28 Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
IL272308A IL272308A (en) 2017-08-30 2020-01-28 Use of inhaled nitric oxide for the improvement of right and/or left ventricular function

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL272308A IL272308A (en) 2017-08-30 2020-01-28 Use of inhaled nitric oxide for the improvement of right and/or left ventricular function

Country Status (14)

Country Link
US (2) US20200360647A1 (enExample)
EP (2) EP3675719A4 (enExample)
JP (4) JP2020532531A (enExample)
KR (1) KR20200083443A (enExample)
CN (3) CN111315283A (enExample)
AU (2) AU2018323547A1 (enExample)
BR (1) BR112020004205A2 (enExample)
CA (4) CA3073948A1 (enExample)
IL (2) IL272314A (enExample)
MX (2) MX2020002194A (enExample)
PH (1) PH12020500197A1 (enExample)
SG (1) SG11202000893QA (enExample)
TW (3) TW201919590A (enExample)
WO (2) WO2019046415A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3585726B1 (en) 2017-02-27 2022-09-21 Third Pole, Inc. Systems and methods for generating nitric oxide
JP2020510499A (ja) 2017-02-27 2020-04-09 サード ポール, インコーポレイテッドThird Pole, Inc. 酸化窒素の移動式生成システムおよび方法
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
MX2021008418A (es) * 2019-01-14 2021-08-19 Bellerophon Therapeutics Terapias de farmaco de combinacion de inhibidores de fosfodiesterasa tipo 5 (pde-5) y oxido nitrico inhalado.
EP3969415A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ELECTRODES FOR NITRIC OXIDE GENERATION
EP3969416A4 (en) 2019-05-15 2023-11-01 Third Pole, Inc. SYSTEMS AND DEVICES FOR GENERATING NITROGEN OXIDE
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
US12239460B2 (en) * 2020-05-06 2025-03-04 Janssen Pharmaceuticals, Inc. Controlling operation of drug administration devices using surgical hubs
CA3180709A1 (en) * 2020-05-29 2021-12-02 Martin DEKKER Method for pulsatile delivery of a gaseous drug
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
EP4405019A4 (en) 2021-09-23 2025-07-16 Third Pole Inc SYSTEMS AND METHODS FOR PROVIDING NITRIC OXIDE

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2952193A1 (en) * 2006-12-12 2015-12-09 Gilead Sciences, Inc. Composition for treating a pulmonary hypertension
US7943667B2 (en) * 2007-10-11 2011-05-17 Duke University Potentiating the effect of compound comprising nitric oxide
EP2247297B1 (en) * 2008-01-31 2019-01-09 Vanderbilt University Therapeutic treatment for lung conditions
CA2671029A1 (en) * 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments
CA2819854A1 (en) * 2010-12-03 2012-06-07 Geno Llc Nitric oxide treatments
AU2013267418B2 (en) * 2012-05-31 2018-06-07 Mallinckrodt Hospital Products IP Limited Methods of administering nitric oxide to arterial or arterialized blood
US9795756B2 (en) * 2012-12-04 2017-10-24 Mallinckrodt Hospital Products IP Limited Cannula for minimizing dilution of dosing during nitric oxide delivery
MX360652B (es) * 2012-12-04 2018-11-12 Mallinckrodt Hospital Products Ip Ltd Cánula para minimizar la disolución de la dosificación durante la administración del óxido nítrico.
CA2936490C (en) * 2014-01-10 2022-10-04 Ino Therapeutics Llc Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
WO2015148169A1 (en) * 2014-03-28 2015-10-01 Shape Medical Systems, Inc. Pattern recognition system for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea
BR112018011803A2 (pt) * 2015-12-11 2018-12-04 Vero Biotech LLC método e mecanismo para a administração de gases incluindo óxido nítrico
AU2016382883A1 (en) * 2015-12-28 2018-07-12 Vero Biotech LLC Method and apparatus for administering nitric oxide with supplemental drugs
ES2981050T3 (es) * 2016-02-12 2024-10-07 Mallinckrodt Pharmaceuticals Ireland Ltd Sistema para uso y monitorización de óxido nítrico inhalado con dispositivos de asistencia ventricular izquierda

Also Published As

Publication number Publication date
JP2020532521A (ja) 2020-11-12
TW201912151A (zh) 2019-04-01
CA3266267A1 (en) 2025-04-28
PH12020500197A1 (en) 2020-10-19
IL272308A (en) 2020-03-31
EP3675719A4 (en) 2021-07-14
CN111372577A (zh) 2020-07-03
CN111315283A (zh) 2020-06-19
TW201919590A (zh) 2019-06-01
EP3675719A1 (en) 2020-07-08
SG11202000893QA (en) 2020-02-27
EP3675840A1 (en) 2020-07-08
CA3073948A1 (en) 2019-03-07
CN120131593A (zh) 2025-06-13
WO2019046415A1 (en) 2019-03-07
EP3675840A4 (en) 2021-05-12
CA3266320A1 (en) 2025-05-31
WO2019046413A1 (en) 2019-03-07
JP2020532531A (ja) 2020-11-12
US20200360647A1 (en) 2020-11-19
JP2025029093A (ja) 2025-03-05
BR112020004205A2 (pt) 2020-09-01
TW202416939A (zh) 2024-05-01
TWI887195B (zh) 2025-06-21
JP2023100985A (ja) 2023-07-19
MX2020002194A (es) 2020-11-24
AU2018323547A1 (en) 2020-02-13
MX2025004666A (es) 2025-05-02
CA3073949A1 (en) 2019-03-07
AU2018324004A1 (en) 2020-02-13
KR20200083443A (ko) 2020-07-08
US20200188319A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
IL272314A (en) Use of inhaled nitric oxide for the treatment of pulmonary hypertension associated with lung disease
IL234508B (en) Inhalation of nitric oxide for treating respiratory diseases
CL2015002570A1 (es) Anticuerpos humanos de la proteína f del virus respiratorio sincitial y métodos de uso de estos
EP3400815A4 (en) GESCHMACKSINHALATOR
EP3504988A4 (en) COMBUSTION-FREE AROMA INHALATOR
EP3513667A4 (en) Flavor inhaler
HUE042382T2 (hu) Legyengített Newcastle betegség vírust tartalmazó készítmények és azok alkalmazása neoplázia kezelési eljárásában történõ alkalmazásra
PL3329281T3 (pl) Nieinwazyjne wykrywanie nowotworu pochodzącego z tkanki poza płucem przy użyciu wydychanego powietrza
EP3440948A4 (en) GESCHMACKSINHALATOR
LT2986304T (lt) Farmacinė kompozicija, gydymo būdai ir jų panaudojimas
LT3890767T (lt) Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui
PL3349599T3 (pl) Wziewne preparaty nikotyny oraz sposoby ich wytwarzania i zastosowania
IL275678A (en) Using nitrous oxide and inhaled oxygen to treat pulmonary hypertension
HUE037663T2 (hu) Kalcitonin mimetikumok betegségek és rendellenességek kezelésére
EP3313260A4 (en) PEDIATRIC NOSE ENDOSCOPE, GASTROSCOPE AND AERODIGESTIVSKOP
EP3458076A4 (en) HUMAN RESPIRATORY STEM CELLS IN BREEDING LUNG EPITHEL
HUE062784T2 (hu) Indolinon vegyületek és alkalmazásuk fibrotikus betegségek kezelésében
EP3703660A4 (en) Inhalation of nitric oxide
DK3568181T3 (da) Inhalator
EP4360682C0 (en) INHALER
EP3703562A4 (en) NITRIC OXIDE INHALATION
PL3866775T3 (pl) Cysteamina do zastosowania w leczeniu chorób płuc
UA96897U (uk) Спосіб лікування хронічного обструктивного захворювання легень, поєднаного з остеоартрозом
TR201716209A2 (tr) Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.
TH148366B (th) การใช้อนุพันธ์ไพราโซลในการรักษาการกำเริบแบบเฉียบพลัน ของโรคปอดอุดกั้นชนิดเรื้อรัง